Join
Live feed
·
NEWSReleasevia Quantisnow
Novan Inc. logo
Verrica Pharmaceuticals Inc. logo

Verrica's Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA Approval

ByQuantisnow·Wall Street's wire, on your screen.
NOVN· Novan Inc.VRCA· Verrica Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NOVN (Novan Inc.), VRCA (Verrica Pharmaceuticals Inc.) and more on Quantisnow.